Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic depression: future prospects from recent research.

I N Ferrier1

  • 1School of Neurosciences, University of Newcastle upon Tyne, UK.

International Clinical Psychopharmacology
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A study of wrist-worn activity measurement as a potential real-world biomarker for late-life depression.

Psychological medicine·2016
Same author

Altered hippocampal function in major depression despite intact structure and resting perfusion.

Psychological medicine·2016
Same author

The interrelationship between attentional and executive deficits in major depressive disorder.

Acta psychiatrica Scandinavica·2016
Same author

Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.

Journal of psychopharmacology (Oxford, England)·2016
Same author

Neurocognitive intra-individual variability in mood disorders: effects on attentional response time distributions.

Psychological medicine·2015
Same author

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.

Journal of psychopharmacology (Oxford, England)·2015
Same journal

Critical reassessment of manic and psychotic episodes related to levetiracetam: a systematic review of published case reports.

International clinical psychopharmacology·2026
Same journal

Methylphenidate treatment in adults with comorbid attention-deficit/hyperactivity disorder and borderline personality disorder: a prospective longitudinal study.

International clinical psychopharmacology·2026
Same journal

Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).

International clinical psychopharmacology·2026
Same journal

Drug development in autism spectrum disorder: genetic heterogeneity, failed trials, and the case for stratified pharmacotherapy.

International clinical psychopharmacology·2026
Same journal

Aripiprazole‑induced akathisia associated with bilateral putaminal hypermetabolism on PET.

International clinical psychopharmacology·2026
Same journal

Defining treatment-resistant depression in a real-world setting: impact of a staging model on clinical features and treatment trajectories.

International clinical psychopharmacology·2026
See all related articles

Recent research highlights clinical and epidemiological approaches for chronic depression, emphasizing serotonin (5HT) neurotransmission. Future developments may focus on organic changes and novel prophylactic antidepressants for improved treatment outcomes.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Research

Background:

  • Chronic depression presents significant challenges in understanding and treatment.
  • Serotonin (5HT) neurotransmission is recognized as a key factor in depressive disorders.

Purpose of the Study:

  • To review recent advancements in chronic depression research.
  • To identify future directions for understanding and treating chronic depression.
  • To highlight the potential of novel antidepressant development.

Main Methods:

  • Review of recent clinical and epidemiological research findings.
  • Analysis of the role of serotonin (5HT) in depression.
  • Exploration of the necessity for further investigation into organic changes.

Related Experiment Videos

Main Results:

  • Clinical and epidemiological studies are pivotal for future progress in chronic depression.
  • Adequate serotonin (5HT) neurotransmission appears essential for effective chronic depression treatment.
  • Further research into organic alterations associated with chronic depression is warranted.

Conclusions:

  • Novel antidepressant development, especially prophylactic agents, offers the most promising avenue for substantial clinical benefit.
  • Continued exploration of biological underpinnings and therapeutic strategies is crucial for managing chronic depression.